Biogen (BIIB) FCF Margin (2009 - 2026)

Biogen (BIIB) has reported FCF Margin for 18 consecutive years, with 23.98% the latest figure, recorded in Q1 2026.

• In Q1 2026, FCF Margin rose 1484.0% year-over-year to 23.98%; the TTM figure through Mar 2026 stood at 24.38% (down 44.0% YoY), while the FY2025 annual figure was 20.73%, down 739.0% from the prior year.
• FCF Margin came in at 23.98% for Q1 2026 at Biogen, up from 20.53% in the prior quarter.
• The five-year high for FCF Margin was 48.38% in Q3 2025, with the low at 10.28% in Q4 2022.
• Average FCF Margin over 5 years is 18.53%, with a median of 20.53% recorded in 2025.
• Across the five-year window, FCF Margin sank 3905 bps in 2022 and soared 3161 bps in 2024, its largest moves.
• Year by year, FCF Margin stood at 10.28% in 2022, then jumped by 79 bps to 2.21% in 2023, then soared by 1431 bps to 29.4% in 2024, then sank by 30 bps to 20.53% in 2025, then increased by 17 bps to 23.98% in 2026.
• According to Business Quant data, FCF Margin over the past three periods registered 23.98%, 20.53%, and 48.38% for Q1 2026, Q4 2025, and Q3 2025 respectively.